The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results from the NORA study

Ann Oncol. 2008 Oct;19(10):1811-2. doi: 10.1093/annonc/mdn547. Epub 2008 Aug 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anthracyclines / administration & dosage
  • Anthracyclines / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / enzymology
  • Breast Neoplasms / metabolism
  • Disease-Free Survival
  • Female
  • Humans
  • Middle Aged
  • Receptor, ErbB-2 / metabolism
  • Receptors, Estrogen / biosynthesis
  • Receptors, Progesterone / biosynthesis
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anthracyclines
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Receptor, ErbB-2